Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Serono Extend Proteomics Collaboration

NEW YORK, Aug. 28 (GenomeWeb News) - Inpharmatica said today that its two-year proteomics collaboration with Serono has been extended for an additional year.

The companies first agreed in mid-2001 to the deal, under which Inpharmatica supplies protein sequences to Serono for its drug target discovery efforts. The arrangement was expandedearlier this year to include additional proprietary genomic sequence data from other protein families.

Inpharmatica said that the extension allows Serono to select an unlimited number of novel proteins from those identified, and noted that it comes about two months after the receipt of a milestone payment from Serono triggered by the development of a novel secreted protein.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.